Terms: = Lymphoma AND TCL1A, P56279, 8115, ENSG00000100721, TCL1 AND Treatment
29 results:
1. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract] [Full Text] [Related]
2. From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature.
Nahmod KA; Thakral B; Aakash FNU; Iyer SP; Medeiros LJ; Quesada AE
Ann Diagn Pathol; 2023 Feb; 62():152077. PubMed ID: 36549077
[TBL] [Abstract] [Full Text] [Related]
3. Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo.
Martines C; Chakraborty S; Vujovikj M; Gobessi S; Vaisitti T; Deaglio S; Laurenti L; Dimovski AJ; Efremov DG
Blood; 2022 Dec; 140(22):2335-2347. PubMed ID: 36084319
[TBL] [Abstract] [Full Text] [Related]
4. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract] [Full Text] [Related]
5. AKT: a key to RT?
Brown JR
Blood; 2021 Feb; 137(5):582-584. PubMed ID: 33538799
[TBL] [Abstract] [Full Text] [Related]
6. Current understandings on T-cell prolymphocytic leukemia and its association with tcl1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract] [Full Text] [Related]
7. tcl1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
[TBL] [Abstract] [Full Text] [Related]
8. Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy.
Granata S; Santoro G; Signorini L; Malerba G; Patuzzo C; Gambaro G; Stallone G; Zaza G
Eur J Pharmacol; 2019 Sep; 859():172494. PubMed ID: 31238062
[TBL] [Abstract] [Full Text] [Related]
9. Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies.
Ten Hacken E; Valentin R; Regis FFD; Sun J; Yin S; Werner L; Deng J; Gruber M; Wong J; Zheng M; Gill AL; Seiler M; Smith P; Thomas M; Buonamici S; Ghia EM; Kim E; Rassenti LZ; Burger JA; Kipps TJ; Meyerson ML; Bachireddy P; Wang L; Reed R; Neuberg D; Carrasco RD; Brooks AN; Letai A; Davids MS; Wu CJ
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282833
[TBL] [Abstract] [Full Text] [Related]
10. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
Johnston HE; Carter MJ; Cox KL; Dunscombe M; Manousopoulou A; Townsend PA; Garbis SD; Cragg MS
Mol Cell Proteomics; 2017 Mar; 16(3):386-406. PubMed ID: 28062796
[TBL] [Abstract] [Full Text] [Related]
11. Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.
Zemanova J; Hylse O; Collakova J; Vesely P; Oltova A; Borsky M; Zaprazna K; Kasparkova M; Janovska P; Verner J; Kohoutek J; Dzimkova M; Bryja V; Jaskova Z; Brychtova Y; Paruch K; Trbusek M
Oncotarget; 2016 Sep; 7(38):62091-62106. PubMed ID: 27556692
[TBL] [Abstract] [Full Text] [Related]
12. p53-independent ibrutinib responses in an Eμ-tcl1 mouse model demonstrates efficacy in high-risk CLL.
Lee HJ; Gallardo M; Ma H; Zhang X; Larsson CA; Mejia A; Hornbaker MJ; Qi Y; Su X; Pageon LR; Quintas-Cardama A; Post SM
Blood Cancer J; 2016 Jun; 6(6):e434. PubMed ID: 27284738
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
[TBL] [Abstract] [Full Text] [Related]
14. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
[TBL] [Abstract] [Full Text] [Related]
15. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.
Deng L; Xu-Monette ZY; Loghavi S; Manyam GC; Xia Y; Visco C; Huh J; Zhang L; Zhai Q; Wang Y; Qiu L; Dybkær K; Chiu A; Perry AM; Zhang S; Tzankov A; Rao H; Abramson J; Sohani AR; Xu M; Hsi ED; Zhu J; Ponzoni M; Wang S; Li L; Zhang M; Ferreri AJ; Parsons BM; Li Y; Piris MA; Medeiros LJ; Young KH
Leukemia; 2016 Feb; 30(2):361-72. PubMed ID: 26308769
[TBL] [Abstract] [Full Text] [Related]
16. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Rosenquist R; Cortese D; Bhoi S; Mansouri L; Gunnarsson R
Leuk Lymphoma; 2013 Nov; 54(11):2351-64. PubMed ID: 23480493
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
[TBL] [Abstract] [Full Text] [Related]
19. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract] [Full Text] [Related]
20. tcl1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.
Weng J; Rawal S; Chu F; Park HJ; Sharma R; Delgado DA; Fayad L; Fanale M; Romaguera J; Luong A; Kwak LW; Neelapu SS
Blood; 2012 Aug; 120(8):1613-23. PubMed ID: 22645177
[TBL] [Abstract] [Full Text] [Related]
[Next]
